Here, we identified TRIM29, an important member of TRIM family, as a uniquely enriched protein in recurrent TNBC (post neo-adjuvant chemotherapy) using in silico data analysis comparing TNBC with recurrence to those without recurrence, as well as to all other subtypes of breast cancer. The gene discussed is TRIM29; the disease is breast cancer.